EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intracerebral glioma growth

Yinhsuan Michely Chen, Julien Chambon, Alexandre Moquin, Masakazu Hashimoto, Stephanie Perrino, Matthew Leibovitch, Yasmine Benslimane, Orçun Haçariz, Qin Yang, Ichiro Nakano, Brian Meehan, Janusz Rak und 2 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Yinhsuan Michely Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Experimental Medicine, McGill University. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Nanoparticles, Receptor, IGF Type 1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministère de l'Economie et de l'Innovation du Québec, Ministère de l’Economie et de l’Innovation du Québec.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma is an aggressive brain cancer with a 5-year survival rate of 5–10%. Current therapeutic options are limited, due in part to drug exclusion by the blood–brain barrier, restricting access of targeted drugs to the tumor. The receptor for the type 1 insulin-like growth factor (IGF-1R) was identified as a therapeutic target in glioblastoma. We previously reported that the intracerebral growth of glioma cells with reduced IGF-1R levels was inhibited. The objectives of this study were to evaluate the sensitivity of glioma cells to a novel IGF-axis inhibitor, the IGF-Trap, and optimize its delivery to the brain.

Methods

We tested the effect of the IGF-Trap on the growth of the human glioma stem cells MES-1123 and U87 MG cells, and of murine GL261 cells in vivo, using subcutaneous and orthotopic implantation.

Results

We show that the growth of glioma cells implanted subcutaneously or orthotopically in the brain was inhibited by systemic and direct intracerebral administration of IGF-Trap, respectively, resulting in increased survival. To increase the efficiency of systemic delivery to the brain, we encapsulated the IGF-Trap in trimethyl chitosan (TRIOZAN™) nanoparticles prior to intravenous injection. We found that nanoparticle encapsulation increased the uptake and retention of the IGF-Trap in the brain and resulted in an improved therapeutic effect against intra-cerebrally growing tumors.

Conclusion

Our results identify the IGF-Trap as a potent inhibitor of intracerebral glioma growth and show that encapsulation in nanoparticles can improve delivery of biologics such as the IGF-Trap to the brain, thereby enhancing the therapeutic response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaNanoparticlesReceptor, IGF Type 1AnimalsHumansMiceXenograft Model Antitumor AssaysCell ProliferationCell Line, TumorDrug Delivery SystemsTumor Cells, CulturedMice, Inbred C57BLInsulin-Like Growth Factor I

Stichwörter der Autor:innen

IGF-Trapdrug deliveryglioblastomananoparticlestargeted therapy

Substanzen

Receptor, IGF Type 1Insulin-Like Growth Factor I

Autor:innen und Institutionen

  • Department of Medicine, Division of Experimental Medicine, McGill University.
  • The Research Institute of the McGill University Health Center, Montreal, QC, Canada H4A 3J1.
  • Department of Surgery.
  • Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Pediatrics.
  • Ovensa Innovations Inc, 500 Blvd Cartier O, Laval, QC, CanadaH7V 5B7.

ORCID-Profile: Pnina Brodt

Förderung

  • Ministère de l'Economie et de l'Innovation du Québec
  • Ministère de l’Economie et de l’Innovation du Québec

Zitieren

APA

Chen, Y. M., Chambon, J., Moquin, A., Hashimoto, M., Perrino, S., Leibovitch, M., Benslimane, Y., Haçariz, O., Yang, Q., Nakano, I., Meehan, B., Rak, J., Gagné, S., & Brodt, P. (2025). Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intracerebral glioma growth. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf011

Vancouver

Chen YM, Chambon J, Moquin A, Hashimoto M, Perrino S, Leibovitch M, et al. Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intracerebral glioma growth. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf011

BibTeX
@article{Chen2025,
  author = {Chen, Yinhsuan Michely and Chambon, Julien and Moquin, Alexandre and Hashimoto, Masakazu and Perrino, Stephanie and Leibovitch, Matthew and Benslimane, Yasmine and Haçariz, Orçun and Yang, Qin and Nakano, Ichiro and Meehan, Brian and Rak, Janusz and Gagné, Stéphane and Brodt, Pnina},
  title = {Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intracerebral glioma growth},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf011}
}
Kostenlos starten →